JP Morgan Hologic Aims to Expand Global Reach With Focus on Women's Health At the JP Morgan Healthcare conference, CEO Steve MacMillan especially noted Africa as an underserved market for women's health. PerkinElmer Becoming Pure Play Dx, Life Science Firm, Spurred on by COVID Innovations At the JP Morgan conference, the firm's CEO said that it chose to divest its applied, food, and enterprise businesses due to innovations it achieved during the pandemic. Myriad Genetics Highlights 2023 Product Launches for Women's Health, Oncology Businesses Premium The company is planning to launch a 4-in-1 prenatal screening test, a liquid biopsy test, and a minimal residual disease assay in the coming year. Morgan Health Invests $20M in LetsGetChecked Morgan Health CEO Dan Mendelson said that the investment was in line with the business unit's focus on employee health. UBS, JP Morgan Downgrade Singular Genomics to Neutral Analysts for the two banks cited supply chain and manufacturing issues that have delayed the launch of the G4 sequencing instrument as key reasons for the downgrade. Aug 11, 2022 JP Morgan Downgrades Seer to Neutral Jan 12, 2022 JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More Nov 10, 2021 JP Morgan Initiates Coverage of Oxford Nanopore Technologies With Overweight Rating Aug 25, 2021 PerkinElmer Reaches Deal for $1.5B Credit Facility Aug 17, 2021 JP Morgan, Cowen Initiate Coverage of Sophia Genetics With Overweight, Outperform Ratings Aug 12, 2021 PerkinElmer Enters $500M Credit Facility Jun 21, 2021 JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems May 24, 2021 Singular Genomics Ups IPO Target to $187M May 12, 2021 Sequencing Startup Singular Genomics Files for $100M IPO Feb 18, 2021 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO Jan 14, 2021 JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 2: Qiagen, Invitae, Agilent, Sema4, More Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 12, 2021 Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 1: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 11, 2021 PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan Dec 3, 2020 Twist Bioscience Prices Upsized $300M Public Offering Dec 2, 2020 Twist Bioscience Proposes $250M Public Offering Nov 3, 2020 Pacific Biosciences Gears Up For Commercial, R&D Push With Eye Toward Collaborations Premium Oct 14, 2020 JP Morgan Rates Invitae Neutral Load More Breaking News Bio-Rad Laboratories, Cytek Biosciences Partner on Flow Cytometry Reagents Tecan Inks Deals for NGS Library Prep System With Element Biosciences, Singular Genomics Genomenon, Flagship Biosciences Partner on Biomarker Discovery, Companion Dx Development Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform Evonetix Raises $24M in Extended Series B Funding Round The Scan Study Points to Tuberculosis Protection by Gaucher Disease Mutation A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds. SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource. Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages. UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.